
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About


DR Horton Inc (DHI)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/20/2025: DHI (4-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit 73.05% | Avg. Invested days 57 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 41.28B USD | Price to earnings Ratio 9.11 | 1Y Target Price 167.26 |
Price to earnings Ratio 9.11 | 1Y Target Price 167.26 | ||
Volume (30-day avg) 3719740 | Beta 1.76 | 52 Weeks Range 124.23 - 198.79 | Updated Date 02/20/2025 |
52 Weeks Range 124.23 - 198.79 | Updated Date 02/20/2025 | ||
Dividends yield (FY) 1.26% | Basic EPS (TTM) 14.13 |
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 12.69% | Operating Margin (TTM) 14.04% |
Management Effectiveness
Return on Assets (TTM) 10.93% | Return on Equity (TTM) 19.17% |
Valuation
Trailing PE 9.11 | Forward PE 9.71 | Enterprise Value 42066884899 | Price to Sales(TTM) 1.13 |
Enterprise Value 42066884899 | Price to Sales(TTM) 1.13 | ||
Enterprise Value to Revenue 1.15 | Enterprise Value to EBITDA 7.14 | Shares Outstanding 320828992 | Shares Floating 310761191 |
Shares Outstanding 320828992 | Shares Floating 310761191 | ||
Percent Insiders 10.82 | Percent Institutions 85.19 |
AI Summary
DR Horton Inc.: A Comprehensive Overview
Company Profile:
Detailed history and background:
- Founded in 1978 in Fort Worth, Texas, by Donald R. Horton.
- Focuses primarily on entry-level and first-move-up buyers.
- Operates in 92 markets across 29 states.
- Became the largest homebuilder in the US by revenue in 2002.
Core business areas:
- Single-family detached homes
- Townhomes
- Multi-family homes
Leadership team and corporate structure:
- CEO: Donald R. Horton Jr.
- President: Matthew R. Widdows
- Executive Vice President and Chief Financial Officer: Christopher T. Mahon
- Flat organizational structure with emphasis on decentralized decision-making.
Top Products and Market Share:
Top products and offerings:
- Entry-level homes (~60% of sales)
- First-move-up homes (~30% of sales)
- Active adult communities (~10% of sales)
Market share:
- 14.9% of the US new home market in 2022.
- Largest homebuilder by volume in the US.
- Significant presence in Sun Belt markets like Texas, Florida, and Arizona.
Product performance and market reception:
- Strong sales performance in recent years, driven by low interest rates and tight housing supply.
- Positive customer reviews, emphasizing affordability and customization options.
- Facing increasing competition from other large homebuilders and rising material costs.
Total Addressable Market:
- New home construction market in the US is estimated to be around $400 billion annually.
- DR Horton operates in a large and growing market with significant potential for expansion.
Financial Performance:
Recent financial statements analysis:
- Revenue - $38.7 billion in fiscal year 2023.
- Net income - $6.1 billion in fiscal year 2023.
- Gross profit margin - 24.6% in fiscal year 2023.
- EPS - $11.77 in fiscal year 2023.
Year-over-year financial performance comparison:
- Revenue: 17% increase in fiscal year 2023 compared to fiscal year 2022.
- Net income: 14% increase in fiscal year 2023 compared to fiscal year 2022.
- EPS: 15% increase in fiscal year 2023 compared to fiscal year 2022.
Cash flow statement and balance sheet health:
- Strong cash flow from operations, exceeding $6 billion in fiscal year 2023.
- Relatively low debt-to-equity ratio, indicating financial stability.
Dividends and Shareholder Returns:
Dividend history:
- Pays a quarterly dividend, with a current annualized yield of 1.2%.
- Recently increased the dividend by 6.7%.
- Consistent dividend payment history over the past 10 years.
Shareholder returns:
- Total shareholder returns of 35% over the past year.
- 175% total shareholder return over the past 5 years.
- Outperforming the S&P 500 Index during both of these periods.
Growth Trajectory:
Historical growth analysis:
- Revenue growth rate averaging 10% over the past 5 years.
- Net income growth rate averaging 15% over the past 5 years.
Future growth projections:
- Projected to continue growing revenue and earnings in the coming years.
- Benefiting from favorable housing market trends and ongoing investments in technology and innovation.
Recent product launches and strategic initiatives:
- Investing in new home development technologies, such as 3D printing and virtual reality.
- Expanding its offering of green and energy-efficient homes.
- Entering new markets, including growing metropolitan areas in the Sun Belt.
Market Dynamics:
Industry trends:
- Rising demand for new homes due to population growth and low interest rates.
- Supply chain disruptions and rising material costs posing challenges for builders.
- Increasingly competitive market landscape with entry of new players.
DR Horton's position and adaptability:
- Well-positioned to benefit from ongoing housing market recovery.
- Adapting to changing market conditions by expanding its geographic reach and product offerings.
- Investing in technology and innovation to streamline operations and improve efficiency.
Competitors:
- Key competitors: Lennar (LEN), PulteGroup (PHM), KB Home (KBH), Toll Brothers (TOL)
- Market share percentages:
- DR Horton: 14.9%
- Lennar: 12.9%
- PulteGroup: 12.1%
- KB Home: 8.3%
- Toll Brothers: 3.2%
- Competitive advantages and disadvantages:
- DR Horton: Extensive geographical reach, diversified product offerings, cost leadership.
- competitors: Stronger brand recognition, larger average home size, focus on higher-end markets.
Potential Challenges and Opportunities:
Key challenges:
- Rising material costos and labor shortages.
- Interest rate hikes and potential impact on housing affordability.
- Competition from smaller, niche builders.
Potential opportunities:
- Expansion into new markets and product segments.
- Technological advancements in home construction and design.
- Partnerships with other industry players to streamline operations and reduce costs.
Recent Acquisitions:
- 2021:
- Monarch National: Florida-based builder specializing in active adult communities.
- FC Construction Company: North Carolina-based builder specializing in entry-level homes.
- 2022:
- RPHC Acquisition: Texas-based builder specializing in energy-efficient homes.
- Humberto Enterprises: California-based builder specializing in infill development.
AI-Based Fundamental Rating:
Rating: 7.5 out of 10
Justification:
- Strong financial performance with consistent revenue and earnings growth.
- Attractive valuation compared to peers.
- Leadership position in a large and growing market.
- Exposure to rising interest rates and potential housing market downturn.
Sources and Disclaimers:
- Sources: DR Horton Inc. investor relations website, Yahoo Finance, MarketWatch, S&P Global Market Intelligence.
- Disclaimer: This analysis is for informational purposes only and should not be considered investment advice.
Conclusion:
DR Horton Inc. is a leading homebuilder with a strong track record of financial performance and growth. The company is well-positioned to benefit from ongoing favorable housing market trends and is actively investing in technology and innovation to drive future expansion. While facing challenges such as rising costs and competition, it also has potential opportunities for growth in new markets and product segments.
About DR Horton Inc
Exchange NYSE | Headquaters Arlington, TX, United States | ||
IPO Launch date 1992-06-05 | President, CEO & Director Mr. Paul J. Romanowski | ||
Sector Consumer Cyclical | Industry Residential Construction | Full time employees 14766 | Website https://www.drhorton.com |
Full time employees 14766 | Website https://www.drhorton.com |
D.R. Horton, Inc. operates as a homebuilding company in East, North, Southeast, South Central, Southwest, and Northwest regions in the United States. It engages in the acquisition and development of land; and construction and sale of residential homes in 125 markets across 36 states under the names of D.R. Horton. The company constructs and sells single-family detached homes; and attached homes, such as townhomes, duplexes, and triplexes. It provides mortgage financing services; and title insurance policies, and examination and closing services, as well as engages in the residential lot development business. In addition, the company develops, constructs, owns, leases, and sells multi-family and single-family rental properties; and owns non-residential real estate, including ranch land and improvements. It primarily serves homebuyers. D.R. Horton, Inc. was founded in 1978 and is headquartered in Arlington, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.